Cargando…
Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing()
INTRODUCTION: Transforming growth factor-beta 1(TGF-β1) is a regulatory protein, involved in bone fracture healing. Circulating TGF-β1 levels have been reported to be a predictor of delayed bone healing and non-union, suggesting active relationship between tissue and circulating TGF-β1 in fracture h...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135818/ https://www.ncbi.nlm.nih.gov/pubmed/21529804 http://dx.doi.org/10.1016/j.injury.2011.03.055 |
_version_ | 1782208145354915840 |
---|---|
author | Sarahrudi, Kambiz Thomas, Anita Mousavi, Mehdi Kaiser, Georg Köttstorfer, Julia Kecht, Mathias Hajdu, S. Aharinejad, S. |
author_facet | Sarahrudi, Kambiz Thomas, Anita Mousavi, Mehdi Kaiser, Georg Köttstorfer, Julia Kecht, Mathias Hajdu, S. Aharinejad, S. |
author_sort | Sarahrudi, Kambiz |
collection | PubMed |
description | INTRODUCTION: Transforming growth factor-beta 1(TGF-β1) is a regulatory protein, involved in bone fracture healing. Circulating TGF-β1 levels have been reported to be a predictor of delayed bone healing and non-union, suggesting active relationship between tissue and circulating TGF-β1 in fracture healing. The purpose of this study was to analyse TGF-β1 local and serum concentrations in fracture healing to further contribute to the understanding of molecular regulation of fracture healing. PATIENTS AND METHODS: Serum samples of 113 patients with long bone fractures were collected over a period of 6 months following a standardised time schedule. TGF-β1 serum concentrations were measured using ELISA. Patients were assigned to 2 groups: Group 1 contained 103 patients with physiological healing. Group 2 contained 10 patients with impaired healing. Patients in both groups were matched. One patient of the group 2 had to be excluded because of missing match partner. In addition, fracture haematoma from 11 patients of group 1 was obtained to analyse local TGF-β1 concentrations. 33 volunteers donated serum which served as control. RESULTS: TGF-β1 serum concentrations increased during the early healing period and were significantly higher in patients with physiological healing compared to controls (P = 0.04). Thereafter, it decreased continuously between weeks 2 and 8 and fell again after week 8. TGF-β1 serum concentrations in patients with physiological healing were significantly higher at week 24 compared to controls (P = 0.05). In non-unions, serum concentrations differed significantly from those of controls at week 6 (P = 0.01). No significant difference in between patients with physiological and impaired fracture healing was observed. Fracture haematoma contained significantly higher TGF-β1 concentrations than peripheral serum of the patients (P = 0.017). CONCLUSION: Elevated levels of TGF-β1 in haematoma and in serum after bone fracture especially during the entire healing process indicate its importance for fracture healing. |
format | Online Article Text |
id | pubmed-3135818 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-31358182011-08-01 Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing() Sarahrudi, Kambiz Thomas, Anita Mousavi, Mehdi Kaiser, Georg Köttstorfer, Julia Kecht, Mathias Hajdu, S. Aharinejad, S. Injury Article INTRODUCTION: Transforming growth factor-beta 1(TGF-β1) is a regulatory protein, involved in bone fracture healing. Circulating TGF-β1 levels have been reported to be a predictor of delayed bone healing and non-union, suggesting active relationship between tissue and circulating TGF-β1 in fracture healing. The purpose of this study was to analyse TGF-β1 local and serum concentrations in fracture healing to further contribute to the understanding of molecular regulation of fracture healing. PATIENTS AND METHODS: Serum samples of 113 patients with long bone fractures were collected over a period of 6 months following a standardised time schedule. TGF-β1 serum concentrations were measured using ELISA. Patients were assigned to 2 groups: Group 1 contained 103 patients with physiological healing. Group 2 contained 10 patients with impaired healing. Patients in both groups were matched. One patient of the group 2 had to be excluded because of missing match partner. In addition, fracture haematoma from 11 patients of group 1 was obtained to analyse local TGF-β1 concentrations. 33 volunteers donated serum which served as control. RESULTS: TGF-β1 serum concentrations increased during the early healing period and were significantly higher in patients with physiological healing compared to controls (P = 0.04). Thereafter, it decreased continuously between weeks 2 and 8 and fell again after week 8. TGF-β1 serum concentrations in patients with physiological healing were significantly higher at week 24 compared to controls (P = 0.05). In non-unions, serum concentrations differed significantly from those of controls at week 6 (P = 0.01). No significant difference in between patients with physiological and impaired fracture healing was observed. Fracture haematoma contained significantly higher TGF-β1 concentrations than peripheral serum of the patients (P = 0.017). CONCLUSION: Elevated levels of TGF-β1 in haematoma and in serum after bone fracture especially during the entire healing process indicate its importance for fracture healing. Elsevier 2011-08 /pmc/articles/PMC3135818/ /pubmed/21529804 http://dx.doi.org/10.1016/j.injury.2011.03.055 Text en © 2011 Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/3.0/ Open Access under CC BY-NC-ND 3.0 (https://creativecommons.org/licenses/by-nc-nd/3.0/) license |
spellingShingle | Article Sarahrudi, Kambiz Thomas, Anita Mousavi, Mehdi Kaiser, Georg Köttstorfer, Julia Kecht, Mathias Hajdu, S. Aharinejad, S. Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing() |
title | Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing() |
title_full | Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing() |
title_fullStr | Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing() |
title_full_unstemmed | Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing() |
title_short | Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing() |
title_sort | elevated transforming growth factor-beta 1 (tgf-β1) levels in human fracture healing() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135818/ https://www.ncbi.nlm.nih.gov/pubmed/21529804 http://dx.doi.org/10.1016/j.injury.2011.03.055 |
work_keys_str_mv | AT sarahrudikambiz elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing AT thomasanita elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing AT mousavimehdi elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing AT kaisergeorg elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing AT kottstorferjulia elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing AT kechtmathias elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing AT hajdus elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing AT aharinejads elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing |